E-LIB Suche - Ergebnisse für: Pierre‐Yves Dumas

1

Outcomes of acute myeloid leukemia patients who responded t..:

Garciaz, Sylvain ; Dumas, Pierre‐Yves ; Bertoli, Sarah...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

2

Imatinib with intensive chemotherapy in AML with t(9;22)(q3..:

Gondran, Camille ; Dumas, Pierre-Yves ; Bérard, Emilie...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Artificial intelligence-based prediction models for acute m..:

Didi, Ibrahim ; Alliot, Jean-Marc ; Dumas, Pierre-Yves...
Leukemia Research. 136 (2024) - p. 107437 , 2024

Link: https://doi.org/10.1016/..

4

Dismal outcome of refractory or relapsing patients with mye..:

Leroy, Harmony ; Gadaud, Noémie ; Bérard, Emilie...
Cancer Medicine. 13 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

5

Clinico‐biological features, treatment and prognosis of pri..:

Belhadj, Maya ; Burroni, Barbara ; Kosmider, Olivier...
British Journal of Haematology. 202 (2023) 6 - p. , 2023

Link: https://doi.org/10.1111/..

6

AML-477 Real-World Treatment Patterns and Patient Character..:

Mehta, Priyanka ; Zeidner, Joshua ; Muluneh, Benyam...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S305 , 2023

Link: https://doi.org/10.1016/..

7

Impact of Mutational Status and Prognostic Factors on Survi..:

Dussiau, Charles ; Dupuy, Henry ; Bidet, Audrey...
HemaSphere. 7 (2023) 3 - p. e847 , 2023

Link: https://doi.org/10.1097/..

8

LSC17 score complements genetics and measurable residual di..:

Vasseur, Loïc ; Fenwarth, Laurène ; Lambert, Jérôme...
Blood Advances. 7 (2023) 15 - p. 4024-4034 , 2023

Link: https://doi.org/10.1182/..

9

Overlapping features of therapy-related and de novo NPM1-mu..:

Othman, Jad ; Meggendorfer, Manja ; Tiacci, Enrico...
Blood. 141 (2023) 15 - p. 1846-1857 , 2023

Link: https://doi.org/10.1182/..

10

AML consolidation therapy: timing matters:

Reimann, Adrian-Manuel ; Schalk, Enrico ; Jost, Felix...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 15 - p. 13811-13821 , 2023

Link: https://doi.org/10.1007/..

11

POSTER: AML-477 Real-World Treatment Patterns and Patient C..:

Mehta, Priyanka ; Zeidner, Joshua ; Muluneh, Benyam...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S163 , 2023

Link: https://doi.org/10.1016/..

12

CO3-3 Impact de la diminution du seuil transfusionnel en hé..:

Puntous, Maryse ; Botella, Carmen ; Dumas, Pierre-Yves...
Transfusion Clinique et Biologique. 30 (2023) - p. S40-S41 , 2023

Link: https://doi.org/10.1016/..

13

Cost comparison of post-remission strategies in younger and..:

Mounie, Michael ; Dumas, Pierre-Yves ; Liva-Yonnet, Sandra...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

VANDA regimen followed by blinatumomab leads to favourable ..:

Heraudet, Luc ; Galtier, Jean ; Favre, Simon...
British Journal of Haematology. 198 (2022) 3 - p. 523-527 , 2022

Link: https://doi.org/10.1111/..

15

Gilteritinib activity in refractory or relapsed FLT3-mutate..:

Dumas, Pierre-Yves ; Raffoux, Emmanuel ; Bérard, Emilie...
Leukemia. 37 (2022) 1 - p. 91-101 , 2022

Link: https://doi.org/10.1038/..